$14.630
-1.091 (-7.46%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 BlossomHill Therapeutics Inc 股票嗎？
BlossomHill Therapeutics, Inc. is a good buy right now due to its recent FDA Fast Track designation for BH-30643, which has shown a 45% objective response rate in clinical trials. The current price is $14.63, significantly lower than the analyst price target of $40, indicating substantial upside potential. However, the company is currently facing a risk with a negative net income of -$23,758,000 in Q2 2026, which investors should monitor closely.
BLSM 股價於 Friday 收在 $14.63，此前下跌 -7.46%
BlossomHill Therapeutics Inc (BLSM) last closed at $14.63, losing -7.46%. These facts feed the 1-day and 1-week BLSM price prediction above.
預測驅動因素
BlossomHill Therapeutics Inc（BLSM）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
BLSM 季節性分析
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。